Transgene Biote is not listed on NSE
AnnouncementsIntec Capital: Outcome of delisting committee meeting
AnnouncementsDynacons Technologies: Updates on open offer
AnnouncementsIntec Capital: Updates on delisting offer
AnnouncementsIndo-Asian Projects forfeits partly paid-up shares
AnnouncementsAshram Online.Com appoints D. Hemamalini as CFO
AnnouncementsCrompton Greaves: Updates on outcome of AGM
AnnouncementsKushal Tradelink: Outcome of AGM
AnnouncementsBajaj Finserv: Updates on outcome of AGM
38% of moneycontrol users recommend buying Transgene Biote.
What's your call on Transgene Biote today?
Read 1 investor views
|Company Name||Last Price||%
Sical Logistics Recommended on Jun 2nd 2014
Recommended price 85.00 | Peak from reco 129.40 53.14%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Transgene Biote is in the Hospitals & Medical Services sector. The current market capitalisation stands at Rs 49.33 crore.The company has reported a standalone sales of Rs 0.28 crore and a Net Loss of Rs -14.90 crore for the quarter ended Mar 2014.
The company management includes K Koteswara Rao - Chairman & Managing Director, P K Ghosh - Director, S S Marthi - Director.
It is listed on the BSE with a BSE Code of 526139.
Its Registered office is at Plot Nos. 68, 69 & 70, Anrich Industrial Area,,IDA Bollaram Medak District,Andhra Pradesh - 502325.
Their Registrars are XL Softech Systems Ltd.